A retrospective study of patient-tailored FOLFIRINOX as a first-line chemotherapy for patients with advanced biliary tract cancer

A retrospective study of patient-tailored FOLFIRINOX as a first-line chemotherapy for patients with advanced biliary tract cancer

Abstract Background FOLFIRINOX is a pillar first-line regimen in the treatment of pancreatic cancer. Historically, biliary tract cancer (BTC) and pancreatic cancer have been treated similarly with gemcitabine alone or combined with a platinum compound. With growing evidence supporting the role of fl...

Full description

Bibliographic Details
Main Authors: Ayhan Ulusakarya, Abdoulaye Karaboué, Oriana Ciacio, Gabriella Pittau, Mazen Haydar, Pamela Biondani, Yusuf Gumus, Amale Chebib, Wathek Almohamad, Pasquale F. Innominato
Format: Article
Language:English
Published: BMC 2020-06-01
Series:BMC Cancer
Subjects:
FOLFIRINOX
Advanced biliary tract cancer
Real life practice
Cholangiocarcinoma
Online Access:http://link.springer.com/article/10.1186/s12885-020-07004-y

Internet

http://link.springer.com/article/10.1186/s12885-020-07004-y

Similar Items